Reactivation of Hepatitis B After Ibalizumab Therapy for Multidrug-Resistant Human Immunodeficiency Virus

被引：2
作者：
Kaplan, Alyson [1 ]
DeHaan, Elliott [2 ]
Maltz, Charles [1 ]
机构：
[1] New York Presbyterian, Dept Med, Div Gastroenterol & Hepatol, Weill Cornell Sch Med, New York, NY 10065 USA
[2] New York Presbyterian, Dept Med, Div Infect Dis, Weill Cornell Sch Med, New York, NY USA
来源：
ACG CASE REPORTS JOURNAL | 2021年 / 8卷 / 05期
关键词：
MONOCLONAL-ANTIBODY; HIV-1;
D O I：
10.14309/crj.0000000000000594
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Despite the decreasing morbidity associated with the human immunodeficiency virus (HIV), a large percentage of persons with HIV have at least 1 drug resistance mutation. Ibalizumab, a recently approved drug, targets multidrug-resistant HIV. We present a case of reactivation of hepatitis B after initiation of ibalizumab therapy.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The impact on blood donor screening for human immunodeficiency virus, hepatitis C virus, and hepatitis B virus using plasma from frozen-thawed plasma preparation tubes
    Allison, Kirsty M.
    Faddy, Helen M.
    Margaritis, Angelo
    Ismay, Susan
    Marks, Denese C.
    TRANSFUSION, 2016, 56 (02) : 449 - 456
  • [32] Hepatitis B reactivation in a long-term nonprogressor due to nivolumab therapy
    Lake, Adam C.
    AIDS, 2017, 31 (15) : 2115 - 2118
  • [33] Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection
    Turriziani, O.
    Andreoni, M.
    Antonelli, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (10) : 1518 - 1524
  • [34] A New Methodological Approach to the Evaluation of the Course and Conduct of Therapy Patients Co-infected with Human Immunodeficiency Virus and Hepatitis C Virus
    Balmasova, Irina
    Aristanbekova, Maira
    Malova, Elena
    Sepiashvili, Revaz
    ALLERGY, ASTHMA & IMMUNOPHYSIOLOGY: INNOVATIVE TECHNOLOGIES, 2016, : 243 - 249
  • [35] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REACTIVATION FROM LATENCY BY A TAT TRANSDOMINANT NEGATIVE MUTANT
    BALBONI, PG
    BOZZINI, R
    ZUCCHINI, S
    MARCONI, PC
    GROSSI, MP
    CAPUTO, A
    MANSERVIGI, R
    BARBANTIBRODANO, G
    JOURNAL OF MEDICAL VIROLOGY, 1993, 41 (04) : 289 - 295
  • [36] A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection
    Coull, JJ
    Turner, D
    Melby, T
    Betts, MR
    Lanier, R
    Margolis, DM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (05) : 423 - 434
  • [37] Switching Human Immunodeficiency Virus Therapy Basic Principles and Options
    Lima, Danilo Bacic
    Solomon, Daniel A.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (03) : 409 - 422
  • [38] Loss of Asparagine-Linked Glycosylation Sites in Variable Region 5 of Human Immunodeficiency Virus Type 1 Envelope Is Associated with Resistance to CD4 Antibody Ibalizumab
    Toma, Jonathan
    Weinheimer, Steven P.
    Stawiski, Eric
    Whitcomb, Jeannette M.
    Lewis, Stanley T.
    Petropoulos, Christos J.
    Huang, Wei
    JOURNAL OF VIROLOGY, 2011, 85 (08) : 3872 - 3880
  • [39] Changes in Blood B Cell Phenotypes and Epstein-Barr Virus Load in Chronically Human Immunodeficiency Virus-Infected Patients before and after Antiretroviral Therapy
    Richard, Yolande
    Amiel, Corinne
    Jeantils, Vincent
    Mestivier, Denis
    Portier, Alain
    Dhello, Guy
    Feuillard, Jean
    Creidy, Rita
    Nicolas, Jean-Claude
    Raphael, Martine
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (09) : 1424 - 1434
  • [40] Reactivation of Herpes Simplex Virus Type 2 After Initiation of Antiretroviral Therapy
    Tobian, Aaron A. R.
    Grabowski, Mary K.
    Serwadda, David
    Newell, Kevin
    Ssebbowa, Paschal
    Franco, Veronica
    Nalugoda, Fred
    Wawer, Maria J.
    Gray, Ronald H.
    Quinn, Thomas C.
    Reynolds, Steven J.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (05) : 839 - 846
12345